Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Clearblue estimates weeks, Barry Meltzer dies, P&G eliminating phthalates and triclosan, NPLEx adds Delaware

This article was originally published in The Tan Sheet

Executive Summary

P&G Clearblue pregnancy test estimates week of conception; AHPA co-founder Meltzer dies; P&G to eliminate phthalates, triclosan; CSPI, Aloe Science Council square off; Delaware joins NPLEx; IADSA focuses on supplement safety guidelines; Pharmavite expands Alabama facility.

Advertisement

Related Content

California DTSC’s Draft Work Plan Includes Personal Care, But Few Surprises
Maine Proposes Reporting Priority For Phthalates In Some Children’s Products
Antibacterial Soap Decline Likely In Reaction To Triclosan Debate
FDA Says Antiseptics Need Testing Or Face Reformulation, Relabeling
Consent Decree Orders FDA Action On Triclosan OTC Monographs
In Brief: U.K. may consolidate AER system, New York restricts DXM sales, Actavis divests oral contraceptives, homeopathic earache products warned
Zephrex-D, Nexafed Make Marketing Pitch As Meth-Fighting Decongestants
Herbalife Investments Streamline Supply Chain, Attract Industry Talent
J&J Trims Formaldehyde-Releasing Chemicals In Personal Care Items
Aloe, Cascara Sagrada Safety In Laxatives Still Needs Supporting Data – FDA

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106589

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel